FDA Approves Toripalimab for Nasopharyngeal Carcinoma FDA Approves Toripalimab for Nasopharyngeal Carcinoma

This marks the first approval for toripalimab.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news